Evidence map›Paper›PMID 29802296›Full record

SynthesisEuropean journal of clinical nutrition2019

Meta-analysis of the association between the dietary inflammatory index (DII) and breast cancer risk.

Lu Wang, Cun Liu, Chao Zhou, Jing Zhuang, Shifeng Tang, Jintai Yu, Jinhui Tian, Fubin Feng, Lijuan Liu, Tingting Zhang and 1 more

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Saponins in Cancer Treatment: Current Progress and Future Prospects.Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Review
  19. Cancer Progress and Priorities: Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lu WangCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250014, Jinan, Shandong Province, China.
Cun LiuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250014, Jinan, Shandong Province, China.ORCID 0000-0001-8197-9000
Chao ZhouDepartment of Oncology, Weifang Traditional Chinese Hospital, 261041, Weifang, Shandong Province, China.
Jing ZhuangDepartment of Oncology, Weifang Traditional Chinese Hospital, 261041, Weifang, Shandong Province, China.
Shifeng TangDepartment of Oncology, Weifang Traditional Chinese Hospital, 261041, Weifang, Shandong Province, China.
Jintai YuUniversity of California, San Francisco, CA, 94158, USA.
Jinhui TianEvidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, 730000, Lanzhou, Gansu Province, China.
Fubin FengDepartment of Oncology, Weifang Traditional Chinese Hospital, 261041, Weifang, Shandong Province, China.
Lijuan LiuDepartment of Oncology, Weifang Traditional Chinese Hospital, 261041, Weifang, Shandong Province, China.
Tingting ZhangCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 250014, Jinan, Shandong Province, China.
Changgang SunDepartment of Oncology, Affilited Hospital of Weifang Medical University, 261031, Weifang, Shandong Province, China. zhongliuyike@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have reported mixed results on the association between the pro-inflammatory dietary index and risk of breast cancer. We perform this comprehensive meta-analysis to figure out whether high dietary inflammatory index (DII) score is a risk factor for the occurrence of breast cancer.

methodsWe comprehensively searched the PubMed, EMBASE and Cochrane databases to identify included studies updated to September 12, 2017. All studies that reported risk estimates by comparing the highest DII score to the lowest were assessed.

resultsA total of seven observational studies were identified: three case controls and four cohorts, involving 319,993 participants. Overall, the meta-analysis reported that individuals with the highest DII score were associated with a 25% increased risk of breast cancer versus those with the lowest DII score (relative risk [RR] = 1.25; 95% confidence interval [CI] 1.09-1.44; I

conclusionThis meta-analysis suggested that more pro-inflammatory diets (higher DII scores) are associated with increased breast cancer incidence. However, the research is not about significant associations but about moderate effect sizes.

Indexed as

Breast NeoplasmsDietInflammationAdultAgedFemaleHumansMiddle AgedRisk FactorsYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.